Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Small Cell Lung Cancer (SCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03406715
What this trial is testing

Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung CancerLung CancerRelapsed Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 14
Testing effectiveness (Phase 2)Ended earlyNCT01471964
What this trial is testing

Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer MetastaticNon-small Cell Lung Cancer Recurrent
Fox Chase Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT03997968
What this trial is testing

CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

Who this might be right for
MalignancyNon-hodgkin LymphomaMultiple Myeloma+12 more
Cyteir Therapeutics, Inc. 169
Not applicableStudy completedNCT00416689
What this trial is testing

Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer

Who this might be right for
Breast CancerLung CancerNausea and Vomiting
Alliance for Clinical Trials in Oncology 99
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT07099898
What this trial is testing

GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]

Who this might be right for
Neoplasms, Lung
GlaxoSmithKline 420
Testing effectiveness (Phase 2)Ended earlyNCT00084487
What this trial is testing

Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy

Who this might be right for
Extensive Stage Small Cell Lung CancerLimited Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
National Cancer Institute (NCI) 21
Early research (Phase 1)UnknownNCT00006458
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Testing effectiveness (Phase 2)Looking for participantsNCT07189871
What this trial is testing

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more
Radiopharm Theranostics, Ltd 61
Not applicableEnded earlyNCT05891197
What this trial is testing

A Biomarker Screening Protocol for Participants With Solid Tumors

Who this might be right for
Triple Negative Breast CancerNon-small Cell Lung CancerNon Small Cell Lung Cancer+19 more
Lyell Immunopharma, Inc. 10
Not applicableStudy completedNCT01416688
What this trial is testing

S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride

Who this might be right for
Colorectal CancerDermatologic ComplicationsLung Cancer+1 more
SWOG Cancer Research Network 146
Early research (Phase 1)Study completedNCT03595059
What this trial is testing

A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors

Who this might be right for
Advanced Solid Tumors
AbbVie 168
Testing effectiveness (Phase 2)UnknownNCT02504346
What this trial is testing

AZD9291, an Irreversible EGFR-TKI, in Relapsed EGFR-mutated Non-small Cell Lung Cancer Patients Previously Treated With an EGFR-TKI, Coupled to Extensive Translational Studies

Who this might be right for
Lung CancerTargeted Therapy
Oslo University Hospital 200
Early research (Phase 1)Looking for participantsNCT06348797
What this trial is testing

Phase I Clinical Study of α-PD-L1/DLL3 CAR-T in Patients With R/R SCLC

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Sichuan University 30
Testing effectiveness (Phase 2)Study completedNCT01901653
What this trial is testing

Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer

Who this might be right for
Recurrent Small Cell Lung Cancer
Stemcentrx 82
Testing effectiveness (Phase 2)UnknownNCT05975944
What this trial is testing

Study of Selinexor Combined With Olaparib in Relapsed/Refractory Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 49
Testing effectiveness (Phase 2)Study completedNCT00405951
What this trial is testing

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)in Combination With Docetaxel for the Treatment of Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Gemin X 47
Large-scale testing (Phase 3)Active Not RecruitingNCT06505837
What this trial is testing

JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC）

Who this might be right for
Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd. 395
Early research (Phase 1)Study completedNCT00856037
What this trial is testing

Topotecan Hydrochloride and Doxorubicin Hydrochloride in Treating Relapsed or Refractory Small Cell Lung Cancer

Who this might be right for
Recurrent Small Cell Lung Carcinoma
University of Nebraska 22
Early research (Phase 1)Study completedNCT04421352
What this trial is testing

Safety and Tolerability Evaluation of Low-dose Radiation in Combination With CS1001 in Relapsed SCLC Patients

Who this might be right for
Relapsed Small Cell Lung Cancer
CStone Pharmaceuticals 11
Next Page